Unlocking a Combination Therapy for New Onset T1D

A new study is further assessing if a novel combination of drugs could help treat new onset type 1 diabetes University of Florida researchers are ready to launch a new clinical study to examine if a combination of two U.S Food and Drug Administration (FDA) approved drugs, antithymocyte globulin (ATG) and granulocyte colony stimulating factor […]

Volunteer Spotlight – January

Volunteer Spotlight – January

If you’ve been to a JDRF Suncoast Chapter event in the past 8 years, chances are you have already met Tammy Payne, volunteer extraordinaire! Tammy has worked tirelessly for our chapter in many capacities – serving as an Executive Board Member and office volunteer, and has even been on the Walk Committee. She has also […]

One on One – January

One on One – January

Even at the ripe age of 13, Emmabella Rudd is a mover and a shaker! Her diagnosis story is like many others that you may hear, but her positive outlook and “can do attitude” is certainly something to be admired. Emmabella was diagnosed with T1D in kindergarten when she was 5, and remembers feeling sick […]

One on One – December

One on One – December

We are so proud of Cami Lange, a Youth Ambassador for the Florida Suncoast Chapter, she was featured in the November issue of Neapolitan Family with an article about living well with diabetes. Cami who was diagnosed at just 4 years old and is now a sophomore in high school talks about what it’s like […]

A song worth more than a listen

Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]

Advancing a Key Artificial Pancreas Technology

Stable liquid glucagon developed by JDRF partner Xeris evaluated in first clinical study The JDRF Artificial Pancreas (AP) project is focused on accelerating the development of commercially-viable AP systems that better mimic the biological function of the pancreas and reduce the daily burden of managing type 1 diabetes (T1D). To achieve this goal, JDRF funds […]

Improving Beta Cell Health and Survival

JDRF-funded clinical study to test marketed drug to improve beta cell health and survival in T1D JDRF recently awarded a $2.1 million grant to Anath Shalev, M.D., director of the University of Alabama’s (UAB) Comprehensive Diabetes Center, to test the impact of a common blood pressure drug called verapamil on the health and survival of […]

Historic Progress for JDRF Encapsulation Research Program

First people with type 1 diabetes receive experimental encapsulated cell replacement therapies in clinical studies Two JDRF-funded partners have successfully implanted people with type 1 diabetes (T1D) with experimental encapsulated cell replacement therapies in clinical studies. These two programs are running in parallel and are evaluating two distinct encapsulation therapies. Encapsulated cell replacement therapy involves […]

It’s Time to Redefine Type 1 Diabetes

Last month, JDRF co-hosted a workshop where healthcare experts from government, nonprofit agencies and educational institutions discussed expanding the definition of Type 1 Diabetes (T1D) to recognize the earliest stages of human T1D before a person is clinically symptomatic. The benefits of the proposed system could include potentially faster drug development, identification of people living […]